An Alberta study is setting up a clinical trial to investigate if the drug hydroxychloroquine can prevent worsening symptoms — and eventual hospitalization — for people with other health complications who have contracted the coronavirus. "We will be targeting Albertans who are at risk of developing a severe case of COVID-19," study lead Dr. Luanne Metz said in a news release Monday. Alberta Health Services will obtain permission from individuals who have tested positive for COVID-19 to provide their contact information to study researchers. Medications will be delivered to participants in their homes, according to the website for the Alberta Hope COVID-19 Trial. That study is targeting people living with somebody known to be COVID-19 positive or a health-care worker looking after someone who's known to be positive.

Source: CBC News April 13, 2020 20:06 UTC